Genomic testing can reveal inherited variants that may influence biological pathways, but a variant is not automatically a disease, a diagnosis, or the cause of a current symptom. The useful question is whether a finding helps you and your clinician ask a better question about the person in front of you.
Last reviewed by Mary Margaret Burch, FNP-BC, FMAPS — September 2026
When your child has struggled for a long time, a genomic report can feel like the first solid thing you have been handed. There are names, pathways, highlighted variants, and pages of information that seem more concrete than another appointment ending with “we’re not sure.” It is understandable to want the report to explain everything.
Mary’s approach is different: genes are part of the story, not the entire story. A genetic variant may point toward a vulnerability or a pathway worth looking at more closely. It does not tell you, by itself, whether that pathway is causing symptoms today.
Think of genomic information like a road map printed before a trip. The map can show where hills, bridges, and alternate routes exist. It cannot tell you whether there is traffic on that road this morning. For that, you still need to look at what is happening now.
Families hear “genetic testing” used for very different purposes. Separating them protects you from assuming that one kind of test can answer every genetic question.
These categories overlap, but they are not interchangeable. Before paying for any test, ask what question it is supposed to answer.
If this framework is clicking for you and you’re tired of piecing things together from random posts and forums, consider joining the Spectrum Care Hub Learning Community. You’ll get full access to step-by-step biomedical coursework, printable tools, and new lessons added every month. Learn more →
Mary’s article gives a simple example: a finding involving a methylation pathway may justify looking more closely at that pathway. But the next step is not automatically a supplement protocol. The next step is to compare the clue with symptoms, diet, medications, family history, and appropriate laboratory information.
This is where a “variant-first” approach can become expensive. If every highlighted result triggers a new test or product, families can spend thousands of dollars without learning which finding actually mattered.
Start with the clinical problem. Ask whether the genomic finding could reasonably connect to it. Look for the least expensive, most clinically useful way to check that question. Act only when the finding and the clinical picture support the same direction. Then observe whether the change actually helped.
That sequence respects both biology and the family budget.
Used carefully, genomic information can help a clinician notice patterns that might otherwise be missed. It can help explain why one person responds differently from another, identify areas that deserve additional investigation, or suggest that a medication-metabolism question is worth reviewing.
A 2025 study of families participating in an autism whole-genome sequencing research program found that clinically relevant findings could provide diagnostic and counseling value. Newer 2026 autism sequencing studies are also showing that important autism-associated genetic findings occur across diverse ancestries. That matters because much older genetic research overrepresented people of European ancestry.
But “useful” does not mean “complete.” Autism, PANS/PANDAS, developmental differences, immune function, nutrition, environment, sleep, medications, and life experience do not collapse into one genetic explanation.
If you already have a genomic report, you do not need to react to every highlighted item. Pick the one or two findings that seem most relevant to the problem you are actually trying to solve. Bring those to a clinician who understands both genetics and the rest of your medical picture.
If you are considering testing, ask what decision the result could change. If no one can explain what would be done differently after the result, it may not be the best place to spend money right now.
Tools such as IntellxxDNA and MaxGen can organize genomic information into pathways for clinician review. They should support clinical judgment, not replace it. The goal is not to treat a report. The goal is to understand the person.
This section is for education only. These are examples of questions you might consider raising with your healthcare provider. They are not instructions for self-directed intervention.
Why this works: It forces the conversation to begin with a problem that needs solving rather than with the availability of a test.
Why this works: It separates genetic predisposition from current biological function.
Why this works: It protects the family from chasing every highlighted result.
Why this works: It puts cost and burden into the clinical decision rather than treating them as an afterthought.
If this helped you see your child’s behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don’t have to navigate autism and PANS/PANDAS care alone. Join the learning community →
No. Many variants are common and may never cause a problem. A result becomes clinically meaningful only when the type of variant, the gene or pathway, and the person’s medical picture support the same conclusion.
Usually not by itself. It may point toward questions worth investigating, but treatment decisions still require symptoms, history, current medications, examination, and sometimes laboratory data.
No. MTHFR is one part of a much larger network. A variant can affect enzyme efficiency, but it does not tell you by itself whether a child has a current folate, homocysteine, or methylation problem.
No. Medical diagnostic testing is designed to identify variants linked to recognized disorders and is interpreted under clinical genetics standards. Wellness or pathway reports often organize common variants into possible areas of vulnerability and should be interpreted more cautiously.
Genetics contributes substantially to autism, but autism is genetically complex. Some people receive a specific genetic diagnosis; many do not. A genetic finding may explain part of a person’s biology without explaining every feature of their life or health.
Sometimes reanalysis can be useful because gene-disease knowledge changes. Ask a genetics professional whether the original data can be reanalyzed before paying for an entirely new test.
This article is for educational purposes only. It does not constitute medical advice and does not create a provider-patient relationship between the reader and Mary Margaret Burch, FNP-BC, FMAPS, or Spectrum Care Hub LLC. Do not use this article to self-diagnose, self-treat, or make decisions about your child’s care without consultation with a qualified, licensed healthcare provider. Do not start, stop, or change any treatment, medication, supplement, or therapeutic intervention based on this content alone.
Individual children vary significantly in their biology, presentation, and response to interventions. Research findings describe groups and do not predict what will happen for any individual child.
Last reviewed by Mary Margaret Burch, FNP-BC, FMAPS — September 2026.
© 2026 Spectrum Care Hub LLC. All rights reserved. Content is protected under 17 U.S.C. § 101 et seq. Personal, non-commercial use only. Unauthorized reproduction or redistribution is prohibited.